BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: De Milito A, Fais S. Tumor acidity, chemoresistance and proton pump inhibitors. Future Oncol. 2005;1:779-786. [PMID: 16556057 DOI: 10.2217/14796694.1.6.779] [Cited by in Crossref: 167] [Cited by in F6Publishing: 154] [Article Influence: 11.1] [Reference Citation Analysis]
Number Citing Articles
1 Wang BY, Zhang J, Wang JL, Sun S, Wang ZH, Wang LP, Zhang QL, Lv FF, Cao EY, Shao ZM, Fais S, Hu XC. Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer. J Exp Clin Cancer Res 2015;34:85. [PMID: 26297142 DOI: 10.1186/s13046-015-0194-x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 12.0] [Reference Citation Analysis]
2 Huber V, De Milito A, Harguindey S, Reshkin SJ, Wahl ML, Rauch C, Chiesi A, Pouysségur J, Gatenby RA, Rivoltini L. Proton dynamics in cancer. J Transl Med. 2010;8:57. [PMID: 20550689 DOI: 10.1186/1479-5876-8-57] [Cited by in Crossref: 80] [Cited by in F6Publishing: 78] [Article Influence: 6.7] [Reference Citation Analysis]
3 Kruspig B, Zhivotovsky B, Gogvadze V. Mitochondrial substrates in cancer: drivers or passengers? Mitochondrion 2014;19 Pt A:8-19. [PMID: 25179741 DOI: 10.1016/j.mito.2014.08.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
4 Kulshrestha A, Katara GK, Ginter J, Pamarthy S, Ibrahim SA, Jaiswal MK, Sandulescu C, Periakaruppan R, Dolan J, Gilman-Sachs A, Beaman KD. Selective inhibition of tumor cell associated Vacuolar-ATPase 'a2' isoform overcomes cisplatin resistance in ovarian cancer cells. Mol Oncol 2016;10:789-805. [PMID: 26899534 DOI: 10.1016/j.molonc.2016.01.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
5 Ganguly A, Chakraborty P, Banerjee K, Choudhuri SK. The role of a Schiff base scaffold, N-(2-hydroxy acetophenone) glycinate-in overcoming multidrug resistance in cancer. Eur J Pharm Sci 2014;51:96-109. [PMID: 24044945 DOI: 10.1016/j.ejps.2013.09.003] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
6 Nezhadi S, Saadat E, Handali S, Dorkoosh F. Nanomedicine and chemotherapeutics drug delivery: challenges and opportunities. J Drug Target 2021;29:185-98. [PMID: 32772739 DOI: 10.1080/1061186X.2020.1808000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Peppicelli S, Andreucci E, Ruzzolini J, Laurenzana A, Margheri F, Fibbi G, Del Rosso M, Bianchini F, Calorini L. The acidic microenvironment as a possible niche of dormant tumor cells. Cell Mol Life Sci 2017;74:2761-71. [PMID: 28331999 DOI: 10.1007/s00018-017-2496-y] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 8.4] [Reference Citation Analysis]
8 Marino ML, Pellegrini P, Di Lernia G, Djavaheri-Mergny M, Brnjic S, Zhang X, Hägg M, Linder S, Fais S, Codogno P, De Milito A. Autophagy is a protective mechanism for human melanoma cells under acidic stress. J Biol Chem 2012;287:30664-76. [PMID: 22761435 DOI: 10.1074/jbc.M112.339127] [Cited by in Crossref: 111] [Cited by in F6Publishing: 68] [Article Influence: 11.1] [Reference Citation Analysis]
9 Fais S. Evidence-based support for the use of proton pump inhibitors in cancer therapy. J Transl Med 2015;13:368. [PMID: 26597250 DOI: 10.1186/s12967-015-0735-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 4.7] [Reference Citation Analysis]
10 Xu J, Xie R, Liu X, Wen G, Jin H, Yu Z, Jiang Y, Zhao Z, Yang Y, Ji B. Expression and functional role of vacuolar H(+)-ATPase in human hepatocellular carcinoma. Carcinogenesis. 2012;33:2432-2440. [PMID: 22962303 DOI: 10.1093/carcin/bgs277] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 4.5] [Reference Citation Analysis]
11 Marino ML, Fais S, Djavaheri-Mergny M, Villa A, Meschini S, Lozupone F, Venturi G, Della Mina P, Pattingre S, Rivoltini L. Proton pump inhibition induces autophagy as a survival mechanism following oxidative stress in human melanoma cells. Cell Death Dis. 2010;1:e87. [PMID: 21368860 DOI: 10.1038/cddis.2010.67] [Cited by in Crossref: 117] [Cited by in F6Publishing: 118] [Article Influence: 9.8] [Reference Citation Analysis]
12 Lee S, Shanti A. Effect of Exogenous pH on Cell Growth of Breast Cancer Cells. Int J Mol Sci 2021;22:9910. [PMID: 34576073 DOI: 10.3390/ijms22189910] [Reference Citation Analysis]
13 Zhang S, Wang Y, Li SJ. Lansoprazole induces apoptosis of breast cancer cells through inhibition of intracellular proton extrusion. Biochem Biophys Res Commun. 2014;448:424-429. [PMID: 24802401 DOI: 10.1016/j.bbrc.2014.04.127] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
14 Bisht S, Maitra A. Dextran–doxorubicin/chitosan nanoparticles for solid tumor therapy. WIREs Nanomed Nanobiotechnol 2009;1:415-25. [DOI: 10.1002/wnan.43] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 5.5] [Reference Citation Analysis]
15 Walsh M, Fais S, Spugnini EP, Harguindey S, Abu Izneid T, Scacco L, Williams P, Allegrucci C, Rauch C, Omran Z. Proton pump inhibitors for the treatment of cancer in companion animals. J Exp Clin Cancer Res 2015;34:93. [PMID: 26337905 DOI: 10.1186/s13046-015-0204-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
16 Gavriliouk D, Scrimgeour NR, Grigoryev S, Ma L, Zhou FH, Barritt GJ, Rychkov GY. Regulation of Orai1/STIM1 mediated ICRAC by intracellular pH. Sci Rep 2017;7:9829. [PMID: 28851859 DOI: 10.1038/s41598-017-06371-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
17 Xie W, Zhou X, Li Q, Chen L, Ran D. Acid-induced autophagy protects human lung cancer cells from apoptosis by activating ER stress. Experimental Cell Research 2015;339:270-9. [DOI: 10.1016/j.yexcr.2015.11.005] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
18 Riethmüller M, Burger N, Bauer G. Singlet oxygen treatment of tumor cells triggers extracellular singlet oxygen generation, catalase inactivation and reactivation of intercellular apoptosis-inducing signaling. Redox Biol 2015;6:157-68. [PMID: 26225731 DOI: 10.1016/j.redox.2015.07.006] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
19 Ribeiro CC, Monteiro RM, Freitas FP, Retamal C, Teixeira LR, Palma LM, Silva FE, Façanha AR, Okorokova-Façanha AL, Okorokov LA. Extracellular glucose increases the coupling capacity of the yeast V H+-ATPase and the resistance of its H+ transport activity to nitrate inhibition. PLoS One 2012;7:e49580. [PMID: 23189149 DOI: 10.1371/journal.pone.0049580] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
20 Serrano-Medina A, Cornejo-Bravo JM, Licea-Claveríe A. Synthesis of pH and temperature sensitive, core-shell nano/microgels, by one pot, soap-free emulsion polymerization. J Colloid Interface Sci 2012;369:82-90. [PMID: 22226474 DOI: 10.1016/j.jcis.2011.12.045] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
21 Müller SS, Fritz T, Gimnich M, Worm M, Helm M, Frey H. Biodegradable hyperbranched polyether-lipids with in-chain pH-sensitive linkages. Polym Chem 2016;7:6257-68. [DOI: 10.1039/c6py01308b] [Cited by in Crossref: 9] [Article Influence: 1.5] [Reference Citation Analysis]
22 Makari Y, Yasuda T, Doki Y, Miyata H, Fujiwara Y, Takiguchi S, Matsuyama J, Yamasaki M, Hirao T, Koyama MK, Nakamuara H, Monden M. Correlation between tumor blood flow assessed by perfusion CT and effect of neoadjuvant therapy in advanced esophageal cancers. J Surg Oncol. 2007;96:220-229. [PMID: 17450532 DOI: 10.1002/jso.20820] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
23 Rashedi J, Ghorbani Haghjo A, Mesgari Abbasi M, Dastranj Tabrizi A, Yaqoubi S, Sanajou D, Ashrafi Jigheh Z, Namvaran A, Mohammadi A, Mohammadi Khoshraj J, Baradaran B. Anti-tumor Effect of Quercetin Loaded Chitosan Nanoparticles on Induced Colon Cancer in Wistar Rats. Adv Pharm Bull 2019;9:409-15. [PMID: 31592135 DOI: 10.15171/apb.2019.048] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Yu H, Cui Z, Yu P, Guo C, Feng B, Jiang T, Wang S, Yin Q, Zhong D, Yang X, Zhang Z, Li Y. pH- and NIR Light-Responsive Micelles with Hyperthermia-Triggered Tumor Penetration and Cytoplasm Drug Release to Reverse Doxorubicin Resistance in Breast Cancer. Adv Funct Mater 2015;25:2489-500. [DOI: 10.1002/adfm.201404484] [Cited by in Crossref: 185] [Cited by in F6Publishing: 150] [Article Influence: 26.4] [Reference Citation Analysis]
25 Shen Y, Tang H, Radosz M, Van Kirk E, Murdoch WJ. pH-responsive nanoparticles for cancer drug delivery. Methods Mol Biol 2008;437:183-216. [PMID: 18369970 DOI: 10.1007/978-1-59745-210-6_10] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
26 Xu Y, Zheng H, Kang J, Zhang L, Su J, Li H, Sun L. 5-Nitro-2-(3-Phenylpropylamino) Benzoic Acid Induced Drug Resistance to Cisplatin in Human Erythroleukemia Cell Lines. Anat Rec 2011;294:945-52. [DOI: 10.1002/ar.21392] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
27 Huang WC, Swietach P, Vaughan-Jones RD, Ansorge O, Glitsch MD. Extracellular acidification elicits spatially and temporally distinct Ca2+ signals. Curr Biol 2008;18:781-5. [PMID: 18485712 DOI: 10.1016/j.cub.2008.04.049] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 3.4] [Reference Citation Analysis]
28 Yahyanejad S, Theys J, Vooijs M. Targeting Notch to overcome radiation resistance. Oncotarget 2016;7:7610-28. [PMID: 26713603 DOI: 10.18632/oncotarget.6714] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 5.3] [Reference Citation Analysis]
29 Lee ZW, Teo XY, Tay EY, Tan CH, Hagen T, Moore PK, Deng LW. Utilizing hydrogen sulfide as a novel anti-cancer agent by targeting cancer glycolysis and pH imbalance. Br J Pharmacol 2014;171:4322-36. [PMID: 24827113 DOI: 10.1111/bph.12773] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 10.1] [Reference Citation Analysis]
30 Lucien F, Pelletier PP, Lavoie RR, Lacroix JM, Roy S, Parent JL, Arsenault D, Harper K, Dubois CM. Hypoxia-induced mobilization of NHE6 to the plasma membrane triggers endosome hyperacidification and chemoresistance. Nat Commun 2017;8:15884. [PMID: 28635961 DOI: 10.1038/ncomms15884] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
31 Spugnini E, Fais S. Proton pump inhibition and cancer therapeutics: A specific tumor targeting or it is a phenomenon secondary to a systemic buffering? Semin Cancer Biol 2017;43:111-8. [PMID: 28088584 DOI: 10.1016/j.semcancer.2017.01.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 6.4] [Reference Citation Analysis]
32 Themistocleous SC, Yiallouris A, Tsioutis C, Zaravinos A, Johnson EO, Patrikios I. Clinical significance of P-class pumps in cancer. Oncol Lett 2021;22:658. [PMID: 34386080 DOI: 10.3892/ol.2021.12919] [Reference Citation Analysis]
33 Azzarito T, Venturi G, Cesolini A, Fais S. Lansoprazole induces sensitivity to suboptimal doses of paclitaxel in human melanoma. Cancer Lett 2015;356:697-703. [PMID: 25449440 DOI: 10.1016/j.canlet.2014.10.017] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 7.3] [Reference Citation Analysis]
34 Chen Y, Choong LY, Lin Q, Philp R, Wong CH, Ang BK, Tan YL, Loh MC, Hew CL, Shah N. Differential expression of novel tyrosine kinase substrates during breast cancer development. Mol Cell Proteomics. 2007;6:2072-2087. [PMID: 17855441 DOI: 10.1074/mcp.m700395-mcp200] [Cited by in Crossref: 96] [Cited by in F6Publishing: 48] [Article Influence: 6.4] [Reference Citation Analysis]
35 Peyvand P, Vaezi Z, Sedghi M, Dalir N, Ma’mani L, Naderi-manesh H. Imidazolium-based ionic liquid functionalized mesoporous silica nanoparticles as a promising nano-carrier: response surface strategy to investigate and optimize loading and release process for Lapatinib delivery. Pharmaceutical Development and Technology 2020;25:1150-61. [DOI: 10.1080/10837450.2020.1803909] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Mafuru M, Wu S, Mayala H, Msengwa Z, Phillip A, Mgone C. Analysis of Combined Effect of CYP2C19 Genetic Polymorphism and Proton Pump Inhibitors Coadministration on Trough Concentration of Voriconazole. Pharmgenomics Pers Med 2021;14:1379-89. [PMID: 34754219 DOI: 10.2147/PGPM.S329662] [Reference Citation Analysis]
37 Sasidharan A, Chandran P, Menon D, Raman S, Nair S, Koyakutty M. Rapid dissolution of ZnO nanocrystals in acidic cancer microenvironment leading to preferential apoptosis. Nanoscale 2011;3:3657. [DOI: 10.1039/c1nr10272a] [Cited by in Crossref: 87] [Cited by in F6Publishing: 82] [Article Influence: 7.9] [Reference Citation Analysis]
38 Kurz T, Terman A, Gustafsson B, Brunk UT. Lysosomes in iron metabolism, ageing and apoptosis. Histochem Cell Biol 2008;129:389-406. [PMID: 18259769 DOI: 10.1007/s00418-008-0394-y] [Cited by in Crossref: 173] [Cited by in F6Publishing: 165] [Article Influence: 12.4] [Reference Citation Analysis]
39 Ridge NA, Agarwal MS, Fakhreddine MH. Old drug, new trick: proton pump inhibitors find new purpose in cancer care. Oncotarget 2021;12:1861-2. [PMID: 34548903 DOI: 10.18632/oncotarget.28053] [Reference Citation Analysis]
40 Robey IF, Martin NK. Bicarbonate and dichloroacetate: evaluating pH altering therapies in a mouse model for metastatic breast cancer. BMC Cancer 2011;11:235. [PMID: 21663677 DOI: 10.1186/1471-2407-11-235] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
41 Kim J, Kim J, Bae JS. ROS homeostasis and metabolism: a critical liaison for cancer therapy. Exp Mol Med 2016;48:e269. [PMID: 27811934 DOI: 10.1038/emm.2016.119] [Cited by in Crossref: 120] [Cited by in F6Publishing: 120] [Article Influence: 20.0] [Reference Citation Analysis]
42 Fais S. Proton pump inhibitor-induced tumour cell death by inhibition of a detoxification mechanism. J Intern Med. 2010;267:515-525. [PMID: 20433578 DOI: 10.1111/j.1365-2796.2010.02225.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 6.0] [Reference Citation Analysis]
43 Terman A, Kurz T, Navratil M, Arriaga EA, Brunk UT. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid Redox Signal 2010;12:503-35. [PMID: 19650712 DOI: 10.1089/ars.2009.2598] [Cited by in Crossref: 319] [Cited by in F6Publishing: 297] [Article Influence: 26.6] [Reference Citation Analysis]
44 Peetla C, Vijayaraghavalu S, Labhasetwar V. Biophysics of cell membrane lipids in cancer drug resistance: Implications for drug transport and drug delivery with nanoparticles. Adv Drug Deliv Rev 2013;65:1686-98. [PMID: 24055719 DOI: 10.1016/j.addr.2013.09.004] [Cited by in Crossref: 129] [Cited by in F6Publishing: 127] [Article Influence: 14.3] [Reference Citation Analysis]
45 Wang L, Zhu H, Sun W, Liang L, Li H, Han C, Huang W, Zhao B, Peng P, Qin M, Shi L, Mo Y, Huang J. Low expression of bestrophin-2 is associated with poor prognosis in colon cancer. Gene 2021;813:146117. [PMID: 34902511 DOI: 10.1016/j.gene.2021.146117] [Reference Citation Analysis]
46 Xu J, Ji B, Wen G, Yang Y, Jin H, Liu X, Xie R, Song W, Song P, Dong H, Tuo B. Na+/H+ exchanger 1, Na+/Ca2+ exchanger 1 and calmodulin complex regulates interleukin 6-mediated cellular behavior of human hepatocellular carcinoma. Carcinogenesis. 2016;37:290-300. [PMID: 26775040 DOI: 10.1093/carcin/bgw004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
47 Patel A, Spychalski P, Antoszewska M, Regula J, Kobiela J. Proton pump inhibitors and colorectal cancer: A systematic review. World J Gastroenterol 2021; 27(44): 7716-7733 [PMID: 34908809 DOI: 10.3748/wjg.v27.i44.7716] [Reference Citation Analysis]
48 Mazzio EA, Smith B, Soliman KF. Evaluation of endogenous acidic metabolic products associated with carbohydrate metabolism in tumor cells. Cell Biol Toxicol 2010;26:177-88. [PMID: 19784859 DOI: 10.1007/s10565-009-9138-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
49 Ravi Kiran AVVV, Kusuma Kumari G, Krishnamurthy PT, Khaydarov RR. Tumor microenvironment and nanotherapeutics: intruding the tumor fort. Biomater Sci 2021;9:7667-704. [PMID: 34673853 DOI: 10.1039/d1bm01127h] [Reference Citation Analysis]
50 Lu ZN, Tian B, Guo XL. Repositioning of proton pump inhibitors in cancer therapy. Cancer Chemother Pharmacol 2017;80:925-37. [PMID: 28861639 DOI: 10.1007/s00280-017-3426-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
51 Jhaveri KS, Cleary SP, Fischer S, Haider MA, Pargoankar V, Khalidi K, Moshonov H, Gallinger S. Blood oxygen level-dependent liver MRI: can it predict microvascular invasion in HCC? J Magn Reson Imaging. 2013;37:692-699. [PMID: 23125092 DOI: 10.1002/jmri.23858] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
52 Taylor S, Spugnini EP, Assaraf YG, Azzarito T, Rauch C, Fais S. Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach. Drug Resist Updat. 2015; Aug 22. [Epub ahead of print]. [PMID: 26341193 DOI: 10.1016/j.drup.2015.08.004] [Cited by in Crossref: 123] [Cited by in F6Publishing: 122] [Article Influence: 17.6] [Reference Citation Analysis]
53 Chernet BT, Levin M. Transmembrane voltage potential of somatic cells controls oncogene-mediated tumorigenesis at long-range. Oncotarget 2014;5:3287-306. [PMID: 24830454 DOI: 10.18632/oncotarget.1935] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 9.9] [Reference Citation Analysis]
54 Pedersen SF, Hoffmann EK, Novak I. Cell volume regulation in epithelial physiology and cancer. Front Physiol 2013;4:233. [PMID: 24009588 DOI: 10.3389/fphys.2013.00233] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 5.7] [Reference Citation Analysis]
55 Abe-ohya R, Ishikawa T, Shiozawa H, Suda K, Nara F. Identification of metals from osteoblastic ST-2 cell supernatants as novel OGR1 agonists. Journal of Receptors and Signal Transduction 2015;35:485-92. [DOI: 10.3109/10799893.2015.1015736] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
56 Cirilli R, Ferretti R, Gallinella B, De Santis E, Zanitti L, La Torre F. High-performance liquid chromatography enantioseparation of proton pump inhibitors using the immobilized amylose-based Chiralpak IA chiral stationary phase in normal-phase, polar organic and reversed-phase conditions. Journal of Chromatography A 2008;1177:105-13. [DOI: 10.1016/j.chroma.2007.11.027] [Cited by in Crossref: 53] [Cited by in F6Publishing: 46] [Article Influence: 3.8] [Reference Citation Analysis]
57 Chennuru LN, Choppari T, Duvvuri S, Dubey PK. Enantiomeric separation of proton pump inhibitors on new generation chiral columns using LC and supercritical fluid chromatography: Liquid Chromatography. J Sep Science 2013;36:3004-10. [DOI: 10.1002/jssc.201300419] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
58 Pavlatovská B, Machálková M, Brisudová P, Pruška A, Štěpka K, Michálek J, Nečasová T, Beneš P, Šmarda J, Preisler J, Kozubek M, Navrátilová J. Lactic Acidosis Interferes With Toxicity of Perifosine to Colorectal Cancer Spheroids: Multimodal Imaging Analysis. Front Oncol 2020;10:581365. [PMID: 33344237 DOI: 10.3389/fonc.2020.581365] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Banković J, Andrä J, Todorović N, Podolski-Renić A, Milošević Z, Miljković D, Krause J, Ruždijić S, Tanić N, Pešić M. The elimination of P-glycoprotein over-expressing cancer cells by antimicrobial cationic peptide NK-2: the unique way of multi-drug resistance modulation. Exp Cell Res 2013;319:1013-27. [PMID: 23298945 DOI: 10.1016/j.yexcr.2012.12.017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
60 Shao D, Wang Z, Dong W, Zhang X, Zheng X, Xiao X, Wang Y, Zhao X, Zhang M, Li J, Huo Q, Chen L. Facile Synthesis of Core-shell Magnetic Mesoporous Silica Nanoparticles for pH-sensitive Anticancer Drug Delivery. Chem Biol Drug Des 2015;86:1548-53. [DOI: 10.1111/cbdd.12622] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
61 Samarão SS, Teodoro CE, Silva FE, Ribeiro CC, Granato TM, Bernardes NR, Retamal CA, Façanha AR, Okorokova-Façanha AL, Okorokov LA. V H+-ATPase along the yeast secretory pathway: energization of the ER and Golgi membranes. Biochim Biophys Acta 2009;1788:303-13. [PMID: 19059377 DOI: 10.1016/j.bbamem.2008.11.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
62 Witz IP. Tumor-microenvironment interactions: dangerous liaisons. Adv Cancer Res. 2008;100:203-229. [PMID: 18620097 DOI: 10.1016/s0065-230x(08)00007-9] [Cited by in Crossref: 86] [Cited by in F6Publishing: 50] [Article Influence: 6.1] [Reference Citation Analysis]
63 Zocco D, Ferruzzi P, Cappello F, Kuo WP, Fais S. Extracellular vesicles as shuttles of tumor biomarkers and anti-tumor drugs. Front Oncol. 2014;4:267. [PMID: 25340037 DOI: 10.3389/fonc.2014.00267] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 7.8] [Reference Citation Analysis]
64 Maxwell SA, Mousavi-Fard S. Non-Hodgkin's B-cell lymphoma: advances in molecular strategies targeting drug resistance. Exp Biol Med (Maywood) 2013;238:971-90. [PMID: 23986223 DOI: 10.1177/1535370213498985] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
65 Gu M, Zhang Y, Zhou X, Ma H, Yao H, Ji F. Rabeprazole exhibits antiproliferative effects on human gastric cancer cell lines. Oncol Lett 2014;8:1739-44. [PMID: 25202402 DOI: 10.3892/ol.2014.2354] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
66 Fisher L, Fisher A. Acid-Suppressive Therapy and Risk of Infections: Pros and Cons. Clin Drug Investig 2017;37:587-624. [PMID: 28361440 DOI: 10.1007/s40261-017-0519-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
67 Hrgovic I, Glavic Z, Kovacic Z, Mulic S, Zunic L, Hrgovic Z. Repeated administration of inhibitors for ion pumps reduce markedly tumor growth in vivo. Med Arch 2014;68:76-8. [PMID: 24937925 DOI: 10.5455/medarh.2014.68.76-78] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
68 Wu XZ, Xie GR, Chen D. Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma. J Gastroenterol Hepatol 2007;22:1178-82. [PMID: 17559361 DOI: 10.1111/j.1440-1746.2007.04997.x] [Cited by in Crossref: 132] [Cited by in F6Publishing: 124] [Article Influence: 8.8] [Reference Citation Analysis]
69 Zhao X, Zhang N, Huang Y, Dou X, Peng X, Wang W, Zhang Z, Wang R, Qiu Y, Jin M, Kong D. Lansoprazole Alone or in Combination With Gefitinib Shows Antitumor Activity Against Non-small Cell Lung Cancer A549 Cells in vitro and in vivo. Front Cell Dev Biol 2021;9:655559. [PMID: 33959611 DOI: 10.3389/fcell.2021.655559] [Reference Citation Analysis]
70 Tang Y, Xiao G, Shen Z, Zhuang C, Xie Y, Zhang X, Yang Z, Guan J, Shen Y, Chen Y, Lai L, Chen Y, Chen S, Dai Z, Wang R, Wu R. Noninvasive Detection of Extracellular pH in Human Benign and Malignant Liver Tumors Using CEST MRI. Front Oncol 2020;10:578985. [PMID: 33224880 DOI: 10.3389/fonc.2020.578985] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
71 Strambi A, De Milito A. Contribution of pH Alterations to the Tumor Microenvironment. In: Mazurek S, Shoshan M, editors. Tumor Cell Metabolism. Vienna: Springer; 2015. pp. 173-96. [DOI: 10.1007/978-3-7091-1824-5_9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
72 Singh MS, Tammam SN, Shetab Boushehri MA, Lamprecht A. MDR in cancer: Addressing the underlying cellular alterations with the use of nanocarriers. Pharmacol Res 2017;126:2-30. [PMID: 28760489 DOI: 10.1016/j.phrs.2017.07.023] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
73 Gomes AS, Ramos H, Soares J, Saraiva L. p53 and glucose metabolism: an orchestra to be directed in cancer therapy. Pharmacological Research 2018;131:75-86. [DOI: 10.1016/j.phrs.2018.03.015] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 10.5] [Reference Citation Analysis]
74 Federici C, Lugini L, Marino ML, Carta F, Iessi E, Azzarito T, Supuran CT, Fais S. Lansoprazole and carbonic anhydrase IX inhibitors sinergize against human melanoma cells. J Enzyme Inhib Med Chem 2016;31:119-25. [PMID: 27142956 DOI: 10.1080/14756366.2016.1177525] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
75 Ferrari S, Perut F, Fagioli F, Brach Del Prever A, Meazza C, Parafioriti A, Picci P, Gambarotti M, Avnet S, Baldini N, Fais S. Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bed. J Transl Med 2013;11:268. [PMID: 24156349 DOI: 10.1186/1479-5876-11-268] [Cited by in Crossref: 77] [Cited by in F6Publishing: 76] [Article Influence: 8.6] [Reference Citation Analysis]
76 Di Gialleonardo V, Tee SS, Aldeborgh HN, Miloushev VZ, Cunha LS, Sukenick GD, Keshari KR. High-Throughput Indirect Quantitation of 13C Enriched Metabolites Using 1H NMR. Anal Chem 2016;88:11147-53. [PMID: 27749041 DOI: 10.1021/acs.analchem.6b03307] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
77 Sousa D, Lima RT, Vasconcelos MH. Intercellular Transfer of Cancer Drug Resistance Traits by Extracellular Vesicles. Trends Mol Med 2015;21:595-608. [PMID: 26432017 DOI: 10.1016/j.molmed.2015.08.002] [Cited by in Crossref: 81] [Cited by in F6Publishing: 81] [Article Influence: 13.5] [Reference Citation Analysis]
78 Stasyk T, Huber LA. Spatio-Temporal Parameters of Endosomal Signaling in Cancer: Implications for New Treatment Options. J Cell Biochem 2016;117:836-43. [PMID: 26506511 DOI: 10.1002/jcb.25418] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
79 Spugnini EP, Buglioni S, Carocci F, Francesco M, Vincenzi B, Fanciulli M, Fais S. High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors. J Transl Med 2014;12:225. [PMID: 25143012 DOI: 10.1186/s12967-014-0225-y] [Cited by in Crossref: 58] [Cited by in F6Publishing: 50] [Article Influence: 7.3] [Reference Citation Analysis]
80 Lee YJ, Lee DM, Lee SH. Production of Cyr61 protein is modulated by extracellular acidification and PI3K/Akt signaling in prostate carcinoma PC-3 cells. Food Chem Toxicol 2013;58:169-76. [PMID: 23623839 DOI: 10.1016/j.fct.2013.04.035] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
81 Depaoli MR, Bischof H, Eroglu E, Burgstaller S, Ramadani-muja J, Rauter T, Schinagl M, Waldeck-weiermair M, Hay JC, Graier WF, Malli R. Live cell imaging of signaling and metabolic activities. Pharmacology & Therapeutics 2019;202:98-119. [DOI: 10.1016/j.pharmthera.2019.06.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
82 Mellor HR, Callaghan R. Accumulation and distribution of doxorubicin in tumour spheroids: the influence of acidity and expression of P-glycoprotein. Cancer Chemother Pharmacol 2011;68:1179-90. [DOI: 10.1007/s00280-011-1598-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.2] [Reference Citation Analysis]
83 Wang X, Li Y, Li J, Li L, Zhu H, Chen H, Kong R, Wang G, Wang Y, Hu J, Sun B. Cell-in-Cell Phenomenon and Its Relationship With Tumor Microenvironment and Tumor Progression: A Review. Front Cell Dev Biol 2019;7:311. [PMID: 31850347 DOI: 10.3389/fcell.2019.00311] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
84 Ryder C, McColl K, Zhong F, Distelhorst CW. Acidosis promotes Bcl-2 family-mediated evasion of apoptosis: involvement of acid-sensing G protein-coupled receptor Gpr65 signaling to Mek/Erk. J Biol Chem 2012;287:27863-75. [PMID: 22685289 DOI: 10.1074/jbc.M112.384685] [Cited by in Crossref: 45] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
85 Boedtkjer E. Na+,HCO3− cotransporter NBCn1 accelerates breast carcinogenesis. Cancer Metastasis Rev 2019;38:165-78. [DOI: 10.1007/s10555-019-09784-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
86 Shen A, Meng X, Gao X, Xu X, Shao C, Tang Z, Liu Y, Bu W, Wang P. An Adaptable Nanoplatform for Integrating Anatomic and Functional Magnetic Resonance Imaging under a 3.0 T Magnetic Field. Adv Funct Mater 2019;29:1803832. [DOI: 10.1002/adfm.201803832] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
87 Nakajima EC, Van Houten B. Metabolic symbiosis in cancer: refocusing the Warburg lens. Mol Carcinog 2013;52:329-37. [PMID: 22228080 DOI: 10.1002/mc.21863] [Cited by in Crossref: 91] [Cited by in F6Publishing: 95] [Article Influence: 9.1] [Reference Citation Analysis]
88 Kulshrestha A, Katara GK, Ibrahim S, Pamarthy S, Jaiswal MK, Gilman Sachs A, Beaman KD. Vacuolar ATPase 'a2' isoform exhibits distinct cell surface accumulation and modulates matrix metalloproteinase activity in ovarian cancer. Oncotarget 2015;6:3797-810. [PMID: 25686833 DOI: 10.18632/oncotarget.2902] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
89 Griffin N, Goh V. Functional imaging of the bowel. Abdom Imaging 2013;38:1203-13. [PMID: 24008510 DOI: 10.1007/s00261-013-0030-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
90 Qu Y, Dou B, Tan H, Feng Y, Wang N, Wang D. Tumor microenvironment-driven non-cell-autonomous resistance to antineoplastic treatment. Mol Cancer 2019;18:69. [PMID: 30927928 DOI: 10.1186/s12943-019-0992-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
91 Huber V, Camisaschi C, Berzi A, Ferro S, Lugini L, Triulzi T, Tuccitto A, Tagliabue E, Castelli C, Rivoltini L. Cancer acidity: An ultimate frontier of tumor immune escape and a novel target of immunomodulation. Semin Cancer Biol 2017;43:74-89. [PMID: 28267587 DOI: 10.1016/j.semcancer.2017.03.001] [Cited by in Crossref: 215] [Cited by in F6Publishing: 203] [Article Influence: 43.0] [Reference Citation Analysis]
92 Seah KS, Loh JY, Nguyen TTT, Tan HL, Hutchinson PE, Lim KK, Dymock BW, Long YC, Lee EJD, Shen HM, Chen ES. SAHA and cisplatin sensitize gastric cancer cells to doxorubicin by induction of DNA damage, apoptosis and perturbation of AMPK-mTOR signalling. Exp Cell Res. 2018;370:283-291. [PMID: 29959912 DOI: 10.1016/j.yexcr.2018.06.029] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
93 Lee YY, Jeon HK, Hong JE, Cho YJ, Ryu JY, Choi JJ, Lee SH, Yoon G, Kim WY, Do IG, Kim MK, Kim TJ, Choi CH, Lee JW, Bae DS, Kim BG. Proton pump inhibitors enhance the effects of cytotoxic agents in chemoresistant epithelial ovarian carcinoma. Oncotarget 2015;6:35040-50. [PMID: 26418900 DOI: 10.18632/oncotarget.5319] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
94 Ikeda H, Shikata Y, Watanapokasin R, Tashiro E, Imoto M. Metacycloprodigiosin induced cell death selectively in β-catenin-mutated tumor cells. J Antibiot (Tokyo) 2017;70:109-12. [PMID: 27328865 DOI: 10.1038/ja.2016.75] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
95 Patutina O, Chiglintseva D, Bichenkova E, Gaponova S, Mironova N, Vlassov V, Zenkova M. Dual miRNases for Triple Incision of miRNA Target: Design Concept and Catalytic Performance. Molecules 2020;25:E2459. [PMID: 32466298 DOI: 10.3390/molecules25102459] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Pinheiro C, Longatto-Filho A, Ferreira L, Pereira SM, Etlinger D, Moreira MA, Jubé LF, Queiroz GS, Schmitt F, Baltazar F. Increasing expression of monocarboxylate transporters 1 and 4 along progression to invasive cervical carcinoma. Int J Gynecol Pathol. 2008;27:568-574. [PMID: 18753962 DOI: 10.1097/pgp.0b013e31817b5b40] [Cited by in Crossref: 62] [Cited by in F6Publishing: 41] [Article Influence: 4.4] [Reference Citation Analysis]
97 Min KH, Kim J, Bae SM, Shin H, Kim MS, Park S, Lee H, Park R, Kim I, Kim K, Kwon IC, Jeong SY, Lee DS. Tumoral acidic pH-responsive MPEG-poly(β-amino ester) polymeric micelles for cancer targeting therapy. Journal of Controlled Release 2010;144:259-66. [DOI: 10.1016/j.jconrel.2010.02.024] [Cited by in Crossref: 212] [Cited by in F6Publishing: 182] [Article Influence: 17.7] [Reference Citation Analysis]
98 Dixit S, Dubey R, Bhushan R. Normal and polar-organic-phase high-performance liquid chromatographic enantioresolution of omeprazole, rabeprazole, lansoprazole and pantoprazole using monochloro-methylated cellulose-based chiral stationary phase and determination of dexrabeprazole: Direct enantioresolution of chiral sulfoxides. Biomed Chromatogr 2014;28:112-9. [DOI: 10.1002/bmc.2915] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
99 Sasazawa Y, Futamura Y, Tashiro E, Imoto M. Vacuolar H+-ATPase inhibitors overcome Bcl-xL-mediated chemoresistance through restoration of a caspase-independent apoptotic pathway. Cancer Sci 2009;100:1460-7. [PMID: 19459857 DOI: 10.1111/j.1349-7006.2009.01194.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
100 Zhao G, Long L, Zhang L, Peng M, Cui T, Wen X, Zhou X, Sun L, Che L. Smart pH-sensitive nanoassemblies with cleavable PEGylation for tumor targeted drug delivery. Sci Rep 2017;7:3383. [PMID: 28611459 DOI: 10.1038/s41598-017-03111-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
101 Shen G, Li X, Jia YF, Piazza GA, Xi Y. Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol Sin 2013;34:336-41. [PMID: 23377548 DOI: 10.1038/aps.2012.195] [Cited by in Crossref: 93] [Cited by in F6Publishing: 92] [Article Influence: 10.3] [Reference Citation Analysis]
102 Canese R, Mezzanzanica D, Bagnoli M, Indraccolo S, Canevari S, Podo F, Iorio E. In vivo Magnetic Resonance Metabolic and Morphofunctional Fingerprints in Experimental Models of Human Ovarian Cancer. Front Oncol 2016;6:164. [PMID: 27446810 DOI: 10.3389/fonc.2016.00164] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
103 Taddei ML, Pietrovito L, Leo A, Chiarugi P. Lactate in Sarcoma Microenvironment: Much More than just a Waste Product. Cells 2020;9:E510. [PMID: 32102348 DOI: 10.3390/cells9020510] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
104 Hung HI, Klein OJ, Peterson SW, Rokosh SR, Osseiran S, Nowell NH, Evans CL. PLGA nanoparticle encapsulation reduces toxicity while retaining the therapeutic efficacy of EtNBS-PDT in vitro. Sci Rep 2016;6:33234. [PMID: 27686626 DOI: 10.1038/srep33234] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
105 Di Paolo A, Bocci G. Drug distribution in tumors: Mechanisms, role in drug resistance, and methods for modification. Curr Oncol Rep 2007;9:109-14. [DOI: 10.1007/s11912-007-0006-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 3.6] [Reference Citation Analysis]
106 Kurz T, Terman A, Gustafsson B, Brunk UT. Lysosomes and oxidative stress in aging and apoptosis. Biochim Biophys Acta 2008;1780:1291-303. [PMID: 18255041 DOI: 10.1016/j.bbagen.2008.01.009] [Cited by in Crossref: 189] [Cited by in F6Publishing: 184] [Article Influence: 13.5] [Reference Citation Analysis]
107 Chen S, Yang K, Tuguntaev RG, Mozhi A, Zhang J, Wang PC, Liang XJ. Targeting tumor microenvironment with PEG-based amphiphilic nanoparticles to overcome chemoresistance. Nanomedicine 2016;12:269-86. [PMID: 26707818 DOI: 10.1016/j.nano.2015.10.020] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 8.1] [Reference Citation Analysis]
108 Ritt M, Guan JL, Sivaramakrishnan S. Visualizing and manipulating focal adhesion kinase regulation in live cells. J Biol Chem 2013;288:8875-86. [PMID: 23393139 DOI: 10.1074/jbc.M112.421164] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
109 Lugini L, Federici C, Borghi M, Azzarito T, Marino ML, Cesolini A, Spugnini EP, Fais S. Proton pump inhibitors while belonging to the same family of generic drugs show different anti-tumor effect. J Enzyme Inhib Med Chem 2016;31:538-45. [PMID: 26018420 DOI: 10.3109/14756366.2015.1046062] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
110 Fais S. A nonmainstream approach against cancer. J Enzyme Inhib Med Chem 2016;31:882-9. [PMID: 26972280 DOI: 10.3109/14756366.2016.1156105] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
111 Steinbichler TB, Dudás J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova II. Therapy resistance mediated by exosomes. Mol Cancer 2019;18:58. [PMID: 30925921 DOI: 10.1186/s12943-019-0970-x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 21.7] [Reference Citation Analysis]
112 van Kuijk SJ, Parvathaneni NK, Niemans R, van Gisbergen MW, Carta F, Vullo D, Pastorekova S, Yaromina A, Supuran CT, Dubois LJ, Winum J, Lambin P. New approach of delivering cytotoxic drugs towards CAIX expressing cells: A concept of dual-target drugs. European Journal of Medicinal Chemistry 2017;127:691-702. [DOI: 10.1016/j.ejmech.2016.10.037] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
113 Pellegrini P, Strambi A, Zipoli C, Hägg-Olofsson M, Buoncervello M, Linder S, De Milito A. Acidic extracellular pH neutralizes the autophagy-inhibiting activity of chloroquine: implications for cancer therapies. Autophagy 2014;10:562-71. [PMID: 24492472 DOI: 10.4161/auto.27901] [Cited by in Crossref: 115] [Cited by in F6Publishing: 112] [Article Influence: 14.4] [Reference Citation Analysis]
114 Peng S, Yuan X, Lin W, Cai C, Zhang L. pH-responsive controlled release of mesoporous silica nanoparticles capped with Schiff base copolymer gatekeepers: Experiment and molecular dynamics simulation. Colloids Surf B Biointerfaces 2019;176:394-403. [PMID: 30660963 DOI: 10.1016/j.colsurfb.2019.01.024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
115 Spugnini EP, Sonveaux P, Stock C, Perez-Sayans M, De Milito A, Avnet S, Garcìa AG, Harguindey S, Fais S. Proton channels and exchangers in cancer. Biochim Biophys Acta 2015;1848:2715-26. [PMID: 25449995 DOI: 10.1016/j.bbamem.2014.10.015] [Cited by in Crossref: 118] [Cited by in F6Publishing: 113] [Article Influence: 14.8] [Reference Citation Analysis]
116 Logan R, Funk RS, Axcell E, Krise JP. Drug-drug interactions involving lysosomes: mechanisms and potential clinical implications. Expert Opin Drug Metab Toxicol 2012;8:943-58. [PMID: 22616667 DOI: 10.1517/17425255.2012.691165] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
117 Yu J, Shi L, Lin W, Lu B, Zhao Y. UCP2 promotes proliferation and chemoresistance through regulating the NF-κB/β-catenin axis and mitochondrial ROS in gallbladder cancer. Biochem Pharmacol 2020;172:113745. [PMID: 31811866 DOI: 10.1016/j.bcp.2019.113745] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
118 Lee YJ, Bae JH, Kim SA, Kim SH, Woo KM, Nam HS, Cho MK, Lee SH. Cariporide Enhances the DNA Damage and Apoptosis in Acid-tolerable Malignant Mesothelioma H-2452 Cells. Mol Cells 2017;40:567-76. [PMID: 28835017 DOI: 10.14348/molcells.2017.0059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
119 Orij R, Urbanus ML, Vizeacoumar FJ, Giaever G, Boone C, Nislow C, Brul S, Smits GJ. Genome-wide analysis of intracellular pH reveals quantitative control of cell division rate by pH(c) in Saccharomyces cerevisiae. Genome Biol 2012;13:R80. [PMID: 23021432 DOI: 10.1186/gb-2012-13-9-r80] [Cited by in Crossref: 99] [Cited by in F6Publishing: 83] [Article Influence: 9.9] [Reference Citation Analysis]
120 Chen M, Huang SL, Zhang XQ, Zhang B, Zhu H, Yang VW, Zou XP. Reversal effects of pantoprazole on multidrug resistance in human gastric adenocarcinoma cells by down-regulating the V-ATPases/mTOR/HIF-1α/P-gp and MRP1 signaling pathway in vitro and in vivo. J Cell Biochem. 2012;113:2474-2487. [PMID: 22396185 DOI: 10.1002/jcb.24122] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 6.1] [Reference Citation Analysis]
121 Dong Q, Zhou C, Ren H, Zhang Z, Cheng F, Xiong Z, Chen C, Yang J, Gao J, Zhang Y, Xu L, Fang J, Cao Y, Wei H, Wu Z. Lactate-induced MRP1 expression contributes to metabolism-based etoposide resistance in non-small cell lung cancer cells. Cell Commun Signal 2020;18:167. [PMID: 33097055 DOI: 10.1186/s12964-020-00653-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
122 Wang T, Liu G, Wang R. The Intercellular Metabolic Interplay between Tumor and Immune Cells. Front Immunol 2014;5:358. [PMID: 25120544 DOI: 10.3389/fimmu.2014.00358] [Cited by in Crossref: 39] [Cited by in F6Publishing: 48] [Article Influence: 4.9] [Reference Citation Analysis]
123 Liu P, Chen H, Han L, Zou X, Shen W. Expression and role of V1A subunit of V-ATPases in gastric cancer cells. Int J Clin Oncol 2015;20:725-35. [PMID: 25652905 DOI: 10.1007/s10147-015-0782-y] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
124 Carvalho TMA, Di Molfetta D, Greco MR, Koltai T, Alfarouk KO, Reshkin SJ, Cardone RA. Tumor Microenvironment Features and Chemoresistance in Pancreatic Ductal Adenocarcinoma: Insights into Targeting Physicochemical Barriers and Metabolism as Therapeutic Approaches. Cancers (Basel) 2021;13:6135. [PMID: 34885243 DOI: 10.3390/cancers13236135] [Reference Citation Analysis]
125 Lozupone F, Borghi M, Marzoli F, Azzarito T, Matarrese P, Iessi E, Venturi G, Meschini S, Canitano A, Bona R, Cara A, Fais S. TM9SF4 is a novel V-ATPase-interacting protein that modulates tumor pH alterations associated with drug resistance and invasiveness of colon cancer cells. Oncogene 2015;34:5163-74. [PMID: 25659576 DOI: 10.1038/onc.2014.437] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 6.3] [Reference Citation Analysis]
126 Clawson C, Ton L, Aryal S, Fu V, Esener S, Zhang L. Synthesis and characterization of lipid-polymer hybrid nanoparticles with pH-triggered poly(ethylene glycol) shedding. Langmuir 2011;27:10556-61. [PMID: 21806013 DOI: 10.1021/la202123e] [Cited by in Crossref: 62] [Cited by in F6Publishing: 54] [Article Influence: 5.6] [Reference Citation Analysis]
127 Azzarito T, Lugini L, Spugnini EP, Canese R, Gugliotta A, Fidanza S, Fais S. Effect of Modified Alkaline Supplementation on Syngenic Melanoma Growth in CB57/BL Mice. PLoS One 2016;11:e0159763. [PMID: 27447181 DOI: 10.1371/journal.pone.0159763] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
128 Harrison MA, Muench SP. The Vacuolar ATPase - A Nano-scale Motor That Drives Cell Biology. Subcell Biochem 2018;87:409-59. [PMID: 29464568 DOI: 10.1007/978-981-10-7757-9_14] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
129 Kulshrestha A, Katara GK, Ibrahim SA, Riehl V, Sahoo M, Dolan J, Meinke KW, Pins MR, Beaman KD. Targeting V-ATPase Isoform Restores Cisplatin Activity in Resistant Ovarian Cancer: Inhibition of Autophagy, Endosome Function, and ERK/MEK Pathway. J Oncol 2019;2019:2343876. [PMID: 31057611 DOI: 10.1155/2019/2343876] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
130 Li JQ, Chen M, Zou XP. PPIs reverse multidrug resistance to chemotherapy in gastric cancer by inhibiting vacuolar H+-ATPase signal pathway. Shijie Huaren Xiaohua Zazhi 2011; 19(31): 3201-3206 [DOI: 10.11569/wcjd.v19.i31.3201] [Reference Citation Analysis]
131 Sanhueza C, Araos J, Naranjo L, Barros E, Subiabre M, Toledo F, Gutiérrez J, Chiarello DI, Pardo F, Leiva A, Sobrevia L. Nitric oxide and pH modulation in gynaecological cancer. J Cell Mol Med 2016;20:2223-30. [PMID: 27469435 DOI: 10.1111/jcmm.12921] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
132 Pérez-sayáns M, Somoza-martín JM, Barros-angueira F, Diz PG, Rey JMG, García-garcía A. Multidrug resistance in oral squamous cell carcinoma: The role of vacuolar ATPases. Cancer Letters 2010;295:135-43. [DOI: 10.1016/j.canlet.2010.03.019] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 4.5] [Reference Citation Analysis]
133 Lener T, Gimona M, Aigner L, Börger V, Buzas E, Camussi G, Chaput N, Chatterjee D, Court FA, Del Portillo HA, O'Driscoll L, Fais S, Falcon-Perez JM, Felderhoff-Mueser U, Fraile L, Gho YS, Görgens A, Gupta RC, Hendrix A, Hermann DM, Hill AF, Hochberg F, Horn PA, de Kleijn D, Kordelas L, Kramer BW, Krämer-Albers EM, Laner-Plamberger S, Laitinen S, Leonardi T, Lorenowicz MJ, Lim SK, Lötvall J, Maguire CA, Marcilla A, Nazarenko I, Ochiya T, Patel T, Pedersen S, Pocsfalvi G, Pluchino S, Quesenberry P, Reischl IG, Rivera FJ, Sanzenbacher R, Schallmoser K, Slaper-Cortenbach I, Strunk D, Tonn T, Vader P, van Balkom BW, Wauben M, Andaloussi SE, Théry C, Rohde E, Giebel B. Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper. J Extracell Vesicles 2015;4:30087. [PMID: 26725829 DOI: 10.3402/jev.v4.30087] [Cited by in Crossref: 614] [Cited by in F6Publishing: 619] [Article Influence: 87.7] [Reference Citation Analysis]
134 Duan S, Yin J, Bai Z, Zhang Z. Effects of taxol resistance gene 1 on the cisplatin response in gastric cancer. Oncol Lett 2018;15:8287-94. [PMID: 29805561 DOI: 10.3892/ol.2018.8390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
135 Zhang H, Lu J, Liu J, Zhang G, Lu A. Advances in the discovery of exosome inhibitors in cancer. J Enzyme Inhib Med Chem 2020;35:1322-30. [PMID: 32543905 DOI: 10.1080/14756366.2020.1754814] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
136 Mendoza EE, Pocceschi MG, Kong X, Leeper DB, Caro J, Limesand KH, Burd R. Control of Glycolytic Flux by AMP-Activated Protein Kinase in Tumor Cells Adapted to Low pH. Transl Oncol 2012;5:208-16. [PMID: 22741040 DOI: 10.1593/tlo.11319] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
137 Alfarouk KO, Muddathir AK, Shayoub ME. Tumor acidity as evolutionary spite. Cancers (Basel) 2011;3:408-14. [PMID: 24310355 DOI: 10.3390/cancers3010408] [Cited by in Crossref: 61] [Cited by in F6Publishing: 59] [Article Influence: 5.5] [Reference Citation Analysis]
138 Samykutty A, Grizzle WE, Fouts BL, McNally MW, Chuong P, Thomas A, Chiba A, Otali D, Woloszynska A, Said N, Frederick PJ, Jasinski J, Liu J, McNally LR. Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle. Biomaterials 2018;182:114-26. [PMID: 30118979 DOI: 10.1016/j.biomaterials.2018.08.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
139 Harguindey S, Arranz JL, Polo Orozco JD, Rauch C, Fais S, Cardone RA, Reshkin SJ. Cariporide and other new and powerful NHE1 inhibitors as potentially selective anticancer drugs--an integral molecular/biochemical/metabolic/clinical approach after one hundred years of cancer research. J Transl Med 2013;11:282. [PMID: 24195657 DOI: 10.1186/1479-5876-11-282] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 10.7] [Reference Citation Analysis]
140 Grimm M, Alexander D, Munz A, Hoffmann J, Reinert S. Increased LDH5 expression is associated with lymph node metastasis and outcome in oral squamous cell carcinoma. Clin Exp Metastasis 2013;30:529-40. [PMID: 23184277 DOI: 10.1007/s10585-012-9557-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
141 Zhong S, Jeong JH, Chen Z, Chen Z, Luo JL. Targeting Tumor Microenvironment by Small-Molecule Inhibitors. Transl Oncol 2020;13:57-69. [PMID: 31785429 DOI: 10.1016/j.tranon.2019.10.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
142 Barar J, Omidi Y. Translational Approaches towards Cancer Gene Therapy: Hurdles and Hopes. Bioimpacts 2012;2:127-43. [PMID: 23678451 DOI: 10.5681/bi.2012.025] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
143 Lugini L, Sciamanna I, Federici C, Iessi E, Spugnini EP, Fais S. Antitumor effect of combination of the inhibitors of two new oncotargets: proton pumps and reverse transcriptase. Oncotarget 2017;8:4147-55. [PMID: 27926505 DOI: 10.18632/oncotarget.13792] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
144 Zhang JL, Liu M, Yang Q, Lin SY, Shan HB, Wang HY, Xu GL. Effects of omeprazole in improving concurrent chemoradiotherapy efficacy in rectal cancer. World J Gastroenterol 2017; 23(14): 2575-2584 [PMID: 28465642 DOI: 10.3748/wjg.v23.i14.2575] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
145 Mueller A, Lalor R, Cardaba CM, Matthews SE. Stable and sensitive probes for lysosomes: cell-penetrating fluorescent calix[4]arenes accumulate in acidic vesicles. Cytometry A 2011;79:126-36. [PMID: 21265006 DOI: 10.1002/cyto.a.21002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
146 Federici C, Petrucci F, Caimi S, Cesolini A, Logozzi M, Borghi M, D'Ilio S, Lugini L, Violante N, Azzarito T, Majorani C, Brambilla D, Fais S. Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin. PLoS One 2014;9:e88193. [PMID: 24516610 DOI: 10.1371/journal.pone.0088193] [Cited by in Crossref: 198] [Cited by in F6Publishing: 195] [Article Influence: 24.8] [Reference Citation Analysis]
147 Ma HI, Hueng DY, Shui HA, Han JM, Wang CH, Lai YH, Cheng SY, Xiao X, Chen MT, Yang YP. Intratumoral decorin gene delivery by AAV vector inhibits brain glioblastomas and prolongs survival of animals by inducing cell differentiation. Int J Mol Sci 2014;15:4393-414. [PMID: 24625664 DOI: 10.3390/ijms15034393] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
148 Kim Y, Jin H, Hong S, Song J, Hwang C, Park I. Silencing of secretory clusterin sensitizes NSCLC cells to V-ATPase inhibitors by downregulating survivin. Biochemical and Biophysical Research Communications 2018;495:2004-9. [DOI: 10.1016/j.bbrc.2017.12.077] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
149 Hebert KA, Jaramillo S, Yu W, Wang M, Veeramachaneni R, Sandulache VC, Sikora AG, Bonnen MD, Annapragada AV, Corry D, Kheradmand F, Pandita RK, Ludwig MS, Pandita TK, Huang S, Coarfa C, Grimm SL, Perera D, Miles G, Ghebre YT. Esomeprazole enhances the effect of ionizing radiation to improve tumor control. Oncotarget 2021;12:1339-53. [PMID: 34262645 DOI: 10.18632/oncotarget.28008] [Reference Citation Analysis]
150 Bohloli M, Atashi A, Soleimani M, Kaviani S, Anbarlou A. Investigating Effects of Acidic pH on Proliferation, Invasion and Drug-Induced Apoptosis in Lymphoblastic Leukemia. Cancer Microenviron 2016;9:119-26. [PMID: 27457339 DOI: 10.1007/s12307-016-0187-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
151 Bauer G. Increasing the endogenous NO level causes catalase inactivation and reactivation of intercellular apoptosis signaling specifically in tumor cells. Redox Biol 2015;6:353-71. [PMID: 26342455 DOI: 10.1016/j.redox.2015.07.017] [Cited by in Crossref: 48] [Cited by in F6Publishing: 37] [Article Influence: 6.9] [Reference Citation Analysis]
152 Fais S. Cannibalism: A way to feed on metastatic tumors. Cancer Letters 2007;258:155-64. [DOI: 10.1016/j.canlet.2007.09.014] [Cited by in Crossref: 92] [Cited by in F6Publishing: 85] [Article Influence: 6.1] [Reference Citation Analysis]
153 Brambilla D, Fais S. The Janus-faced role of ezrin in "linking" cells to either normal or metastatic phenotype. Int J Cancer 2009;125:2239-45. [PMID: 19588507 DOI: 10.1002/ijc.24734] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 2.9] [Reference Citation Analysis]
154 De Milito A, Canese R, Marino ML, Borghi M, Iero M, Villa A, Venturi G, Lozupone F, Iessi E, Logozzi M, Della Mina P, Santinami M, Rodolfo M, Podo F, Rivoltini L, Fais S. pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int J Cancer. 2010;127:207-219. [PMID: 19876915 DOI: 10.1002/ijc.25009] [Cited by in Crossref: 175] [Cited by in F6Publishing: 165] [Article Influence: 14.6] [Reference Citation Analysis]
155 Guan J, Li J, Yan F, Gu H, Li F. Chiral Separation of Tenatoprazole and Several Related Benzimidazoles by Normal Phase LC Using Amylose-Based Stationary Phase. Chroma 2009;70:1039-44. [DOI: 10.1365/s10337-009-1296-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
156 Kiyoshima T, Yoshida H, Wada H, Nagata K, Fujiwara H, Kihara M, Hasegawa K, Someya H, Sakai H. Chemoresistance to concanamycin A1 in human oral squamous cell carcinoma is attenuated by an HDAC inhibitor partly via suppression of Bcl-2 expression. PLoS One 2013;8:e80998. [PMID: 24278362 DOI: 10.1371/journal.pone.0080998] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
157 Consolino L, Anemone A, Capozza M, Carella A, Irrera P, Corrado A, Dhakan C, Bracesco M, Longo DL. Non-invasive Investigation of Tumor Metabolism and Acidosis by MRI-CEST Imaging. Front Oncol 2020;10:161. [PMID: 32133295 DOI: 10.3389/fonc.2020.00161] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]